In Focus, November 2008

Article

News in focus, November 2008

Please click on any of the headlines below to see the full story.

AMD gene discovered
The SERPING1 gene code influences the likelihood of developing age-related macular degeneration (AMD), according to study results published online ahead of print by The Lancet

New way to treat retinopathies suggested
The discovery of factors affecting retinal angiogenesis have implications for the treatment of vascularization disorders, according to results of a study published in the October issue of Nature Medicine

Another use for Avastin… blebs!
Bevacizumab (Avastin) may have an application as an adjunct to antifibrosis therapy, according to study results published in the October/November issue of the Journal of Glaucoma

Congratulations
Competition winners. 

 

For up-to-date news and announcements, please check the latest news section of our website. Alternatively, please sign up for our weekly newsletter.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.